These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 30826571)

  • 21. Sacubitril/Valsartan: A Novel Cardiovascular Combination Agent.
    Sible AM; Nawarskas JJ; Alajajian D; Anderson JR
    Cardiol Rev; 2016; 24(1):41-7. PubMed ID: 26466333
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synergistic effects of combined converting enzyme inhibition and angiotensin II antagonism on blood pressure in conscious telemetered spontaneously hypertensive rats.
    Webb RL; Navarrete AE; Davis S; de Gasparo M
    J Hypertens; 1998 Jun; 16(6):843-52. PubMed ID: 9663925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetic, pharmacodynamic, and antihypertensive effects of the neprilysin inhibitor LCZ-696: sacubitril/valsartan.
    Chrysant SG
    J Am Soc Hypertens; 2017 Jul; 11(7):461-468. PubMed ID: 28652105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-over study comparing effects of treatment with an angiotensin converting enzyme inhibitor and an angiotensin II type 1 receptor antagonist on cardiovascular changes in hypertension.
    Gillies LK; Werstiuk ES; Lee RM
    J Hypertens; 1998 Apr; 16(4):477-86. PubMed ID: 9797193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of heart failure following isoproterenol administration in the rat: role of the renin-angiotensin system.
    Grimm D; Elsner D; Schunkert H; Pfeifer M; Griese D; Bruckschlegel G; Muders F; Riegger GA; Kromer EP
    Cardiovasc Res; 1998 Jan; 37(1):91-100. PubMed ID: 9539862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neprilysin inhibitors: A new hope to halt the diabetic cardiovascular and renal complications?
    Malek V; Gaikwad AB
    Biomed Pharmacother; 2017 Jun; 90():752-759. PubMed ID: 28419972
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Angiotensin receptor-neprilysin inhibitors: clinical potential in heart failure and beyond.
    Singh JS; Lang CC
    Vasc Health Risk Manag; 2015; 11():283-95. PubMed ID: 26082640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The renin angiotensin system and nociception in spontaneously hypertensive rats.
    Irvine RJ; White JM; Head RJ
    Life Sci; 1995 Feb; 56(13):1073-8. PubMed ID: 9001440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved Insulin Sensitivity With Angiotensin Receptor Neprilysin Inhibition in Individuals With Obesity and Hypertension.
    Jordan J; Stinkens R; Jax T; Engeli S; Blaak EE; May M; Havekes B; Schindler C; Albrecht D; Pal P; Heise T; Goossens GH; Langenickel TH
    Clin Pharmacol Ther; 2017 Feb; 101(2):254-263. PubMed ID: 27542885
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined Angiotensin Receptor-Neprilysin Inhibitors Improve Cardiac and Vascular Function Via Increased NO Bioavailability in Heart Failure.
    Trivedi RK; Polhemus DJ; Li Z; Yoo D; Koiwaya H; Scarborough A; Goodchild TT; Lefer DJ
    J Am Heart Assoc; 2018 Mar; 7(5):. PubMed ID: 29502102
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of the novel dual inhibitor of neutral endopeptidase and angiotensin-converting enzyme, CGS 30440, on blood pressure and cardiac hypertrophy in spontaneously hypertensive rats.
    Webb RL; Abramson ML; Beil ME; Odorico LM; Chatelain RE
    J Cardiovasc Pharmacol; 1997 Nov; 30(5):632-42. PubMed ID: 9388046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antihypertensive effects of fasidotril, a dual inhibitor of neprilysin and angiotensin-converting enzyme, in rats and humans.
    Laurent S; Boutouyrie P; Azizi M; Marie C; Gros C; Schwartz JC; Lecomte JM; Bralet J
    Hypertension; 2000 May; 35(5):1148-53. PubMed ID: 10818079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions.
    Burchill LJ; Velkoska E; Dean RG; Griggs K; Patel SK; Burrell LM
    Clin Sci (Lond); 2012 Dec; 123(11):649-58. PubMed ID: 22715807
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Angiotensin receptor neprilysin inhibition for the treatment of hypertension: the neglected child in cardiovascular pharmacotherapy.
    Kjeldsen SE; Atar D; von Lueder TG
    Eur Heart J Cardiovasc Pharmacother; 2019 Apr; 5(2):122-123. PubMed ID: 30698668
    [No Abstract]   [Full Text] [Related]  

  • 35. Effects of omapatrilat in low, normal, and high renin experimental hypertension.
    Trippodo NC; Robl JA; Asaad MM; Fox M; Panchal BC; Schaeffer TR
    Am J Hypertens; 1998 Mar; 11(3 Pt 1):363-72. PubMed ID: 9544878
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of suboptimal doses of the AT1 receptor blocker, telmisartan, with the angiotensin-converting enzyme inhibitor, ramipril, on cerebral arterioles in spontaneously hypertensive rat.
    Dupuis F; Vincent JM; Limiñana P; Chillon JM; Capdeville-Atkinson C; Atkinson J
    J Hypertens; 2010 Jul; 28(7):1566-73. PubMed ID: 20589978
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.
    Tikkanen T; Tikkanen I; Rockell MD; Allen TJ; Johnston CI; Cooper ME; Burrell LM
    Hypertension; 1998 Oct; 32(4):778-85. PubMed ID: 9774379
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of captopril on the renin angiotensin system, oxidative stress, and endothelin in normal and hypertensive rats.
    Bolterman RJ; Manriquez MC; Ortiz Ruiz MC; Juncos LA; Romero JC
    Hypertension; 2005 Oct; 46(4):943-7. PubMed ID: 16087785
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Combination of Valsartan and Sacubitril in the Treatment of Hypertension and Heart Failure - an Update.
    Nielsen PM; Grimm D; Wehland M; Simonsen U; Krüger M
    Basic Clin Pharmacol Toxicol; 2018 Jan; 122(1):9-18. PubMed ID: 28944989
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dual inhibition of angiotensin-converting enzyme and neutral endopeptidase in rats with hypertension.
    French JF; Anderson BA; Downs TR; Dage RC
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):107-13. PubMed ID: 7564349
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.